Zobrazeno 1 - 10
of 429
pro vyhledávání: '"Loretta J. Nastoupil"'
Autor:
Andrew P. Jallouk, Naishu Kui, Ryan Sun, Jason R. Westin, Raphael E. Steiner, Ranjit Nair, Loretta J. Nastoupil, Luis E. Fayad, Ajlan Al Zaki, Misha Hawkins, Sherry Adkins, Mansoor Noorani, Kaberi Das, Jared Henderson, Elizabeth J. Shpall, Partow Kebriaei, Jeremy Ramdial, Christopher R. Flowers, Sattva S. Neelapu, Sairah Ahmed, Paolo Strati
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
Complications occurring after lymphodepleting chemotherapy (LDC) may delay chimeric antigen receptor (CAR) T-cell infusion. The effect of these delays on clinical outcomes is unclear. We performed a retrospective analysis of 240 patients with relapse
Externí odkaz:
https://doaj.org/article/b01259b6f4fa46b6872193b9823dd88d
Autor:
Matthew J. Maurer, Carla Casulo, Melissa C. Larson, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang, Loretta J. Nastoupil, Christopher Strouse, Dai Chihara, Peter Martin, Jonathon B. Cohen, Brad S. Kahl, W Richard Burack, Jean L. Koff, Yong Mun, Anthony Masaquel, Mei Wu, Michael C. Wei, Ashwini Shewade, Jia Li, James R. Cerhan, Brian K. Link, Christopher R. Flowers
Publikováno v:
Haematologica, Vol 999, Iss 1 (2023)
Mosunetuzumab is a novel bispecific antibody targeting epitopes on CD3 on T cells and CD20 on B cells with the goal of inducing T-cell mediated elimination of malignant B cells. A recent pivotal phase I/II clinical trial (GO29781) demonstrated that m
Externí odkaz:
https://doaj.org/article/1d7e46afb331468e9c6f00cad9ff0929
Autor:
Laurie H. Sehn, Nancy L. Bartlett, Matthew Matasar, Stephen J. Schuster, Sarit Assouline, John Kuruvilla, Mazyar Shadman, Chan Cheah, Keith Fay, Matthew Ku, Loretta J. Nastoupil, Michael Wei, Shen Yin, Iris To, Nan Hu, Juliana Min, Elicia Penuel, Anton Belousov, Alexandre Coimbra, Skander Jemaa, Brendan Bender, David Turner, L. Elizabeth Budde
Publikováno v:
HemaSphere, Vol 7, p e36694eb (2023)
Externí odkaz:
https://doaj.org/article/0df5a358399145da83d67731e87be8a3
Autor:
Paolo Strati, Lei Feng, Jason Westin, Ranjit Nair, Sushanth Gouni, Luis Fayad, Maria Rodriguez, Dai Chihara, Luis Malpica, Raphael Steiner, Mariana Gallardo, Loretta J. Nastoupil, Sattva Neelapu
Publikováno v:
HemaSphere, Vol 7, p e6330214 (2023)
Externí odkaz:
https://doaj.org/article/07f72bc945224503956178db4ca6b20e
Autor:
Ian W. Flinn, Caron Jacobson, Loretta J. Nastoupil, Franck Morschhauser, Andrew J. Davies, Christian Buske, Paolo Corradini, Armando Lopez-Guillermo, Ran Reshef, Vinod Parameswaran, Alison Sehgal, Michael Tees, Christine Lui, Wei Xue, Sara Beygi, Nikolay Grechko, Pisita Bolsue, Alessandro Giovanetti, Christina To, Myrna Nahas
Publikováno v:
HemaSphere, Vol 7, p e6350662 (2023)
Externí odkaz:
https://doaj.org/article/ef44d6a08f2940c4843d4ce92bfe510e
Autor:
Antonio Salar Silvestre, Judith Trotman, Clementine Sarkozy, Yuqin Song, Laurie H. Sehn, Loretta J. Nastoupil, Wanhua Zhang, Pierre Fustier, Richard Delarue, Pier Luigi Zinzani
Publikováno v:
HemaSphere, Vol 7, p e5893197 (2023)
Externí odkaz:
https://doaj.org/article/19348e008e05416db3510e8f5c9f1cfe
Autor:
Loretta J. Nastoupil, John Kuruvilla, Julio C. Chavez, Fontanet Bijou, Thomas E. Witzig, Armando Santoro, Ian W. Flinn, Carola Boccomini, Vaishalee P. Kenkre, Paolo Corradini, Iris Isufi, David J. Andorsky, Leonard M. Klein, Daniel R. Greenwald, Randeep Sangha, Frank Shen, Patrick Hagner, Yan Li, Juergen Dobmeyer, Nian Gong, Shailaja Uttamsingh, Michael Pourdehnad, Vincent Ribrag
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 394-405 (2022)
Abstract The multicenter, phase Ib CC‐122‐DLBCL‐001 dose‐expansion study (NCT02031419) explored the cereblon E3 ligase modulator (CELMoD) agent avadomide (CC‐122) plus rituximab in patients with relapsed/refractory (R/R) diffuse large B‐c
Externí odkaz:
https://doaj.org/article/893d9f4d49df48ae90782ee3c1a4ed6c
Autor:
Andrew P. Jallouk, Sushanth Gouni, Jason Westin, Lei Feng, Haleigh Mistry, Raphael E. Steiner, Jinsu James, Mansoor Noorani, Sandra Horowitz, Nahum Puebla-Osorio, Luis E. Fayad, Swaminathan P. Iyer, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta J. Nastoupil, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Yago Nieto, Paolo Strati
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/e594de9ca2264723b1d6eb36952f069d
Autor:
Kevin Tang, Loretta J. Nastoupil
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 150-159 (2021)
Chimeric antigen receptor (CAR) T cell therapy has emerged as a revolutionary treatment option for highly aggressive B cell malignancies. Clinical trials of CD19 CAR T cells for the management of relapsed and/or refractory non-Hodgkin lymphoma (NHL)
Externí odkaz:
https://doaj.org/article/75083ea9e54a4f548f1dffb1fe4fafd3
Autor:
Raphael E. Steiner, Jose Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutierrez, Paolo Strati, Chelsea C. Pinnix, Lei Feng, Gabriela Rondon, Catherine Claussen, Nicolas Palaskas, Kaveh Karimzad, Sairah Ahmed, Sattva S. Neelapu, Elizabeth Shpall, Michael Wang, Francisco Vega, Jason Westin, Loretta J. Nastoupil, Anita Deswal
Publikováno v:
Haematologica, Vol 107, Iss 7 (2021)
Standard of care (SOC) chimeric antigen receptor (CAR) T-cell therapies such as axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) are associated with multisystem toxicities. There is limited information available about cardiovascular
Externí odkaz:
https://doaj.org/article/4db6953f94fd43eca8c9b43427b368b1